TBCE

TBCE (tubulin-specific chaperone E) is an essential component of the tubulin biogenesis and recycling pathway, functioning in the formation, dissociation, and quality control of α/β-tubulin heterodimers and in the routing of tubulin to axons via the Golgi apparatus. TBCE forms a binary complex with TBCB that dissociates tubulin heterodimers through an energy-independent steric mechanism involving its CAP-Gly and LRR domains, generating an αEB ternary complex (TBCE–TBCB–α-tubulin) whose protruding UBL domains can interface with the proteasome for α-tubulin degradation (PMID:17184771, PMID:25908846). As a peripheral membrane-associated protein localized to the Golgi apparatus, TBCE mediates axonal tubulin routing; its destabilization leads to microtubule loss in distal motor and sensory axons, disrupted Golgi and endosomal compartments, and abnormal mitotic spindles (PMID:17699660, PMID:27666369). Loss-of-function mutations in TBCE cause HRD/Sanjad-Sakati syndrome, autosomal recessive Kenny-Caffey syndrome, and progressive encephalopathy with distal spinal muscular atrophy, while the pmn mouse model carrying a destabilizing TBCE missense mutation exhibits progressive motor neuronopathy and sensorineural hearing loss (PMID:12389028, PMID:12389029, PMID:27666369, PMID:24120439).

1. 1997 Medium

   Placing TBCE in a genetic pathway: the yeast ortholog PAC2 was shown to function with CIN1, CIN2, and CIN4 in a tubulin-folding/microtubule-function pathway, establishing the conserved role of this gene family before mammalian characterization.

   Evidence Genetic epistasis, suppressor analysis, and double-mutant phenotyping in S. cerevisiae

   PMID:9215891

   Open questions at the time

   • Yeast PAC2 function not directly extrapolated to mammalian neuron-specific roles
   • No biochemical reconstitution of chaperone activity in this study
2. 2002 High

   Identifying TBCE as the disease gene and establishing its requirement for microtubule integrity: disease-causing mutations in TBCE were identified as the basis of HRD/Sanjad-Sakati syndrome and AR-Kenny-Caffey syndrome in humans, and a destabilizing missense mutation was identified as the cause of progressive motor neuronopathy in pmn mice, with transgenic complementation proving causality.

   Evidence Genetic mapping and mutation identification in patient families; positional cloning in pmn mice; ultrastructural analysis of axonal microtubules; transgenic rescue

   PMID:12389028 PMID:12389029 PMID:12446740

   Open questions at the time

   • Molecular mechanism of microtubule loss not yet defined
   • How TBCE loss causes the specific endocrine (parathyroid) phenotype was unexplained
3. 2006 High

   Defining the biochemical mechanism and subcellular site of action: TBCE was shown to be a Golgi-associated peripheral membrane protein that partners with TBCB to dissociate tubulin heterodimers and form an αEB ternary complex, and TBCE depletion or Golgi disruption compromised axonal tubulin routing, unifying the chaperone and transport functions.

   Evidence In vitro reconstituted dissociation assays, co-immunoprecipitation, subcellular fractionation, RNAi, brefeldin A treatment, and transgenic complementation in motor neurons

   PMID:16938882 PMID:17184771 PMID:17699660

   Open questions at the time

   • The mechanism by which Golgi-localized TBCE selectively routes tubulin to axons versus dendrites was not resolved
   • Whether the ternary complex has additional regulatory inputs was unknown
4. 2013 Medium

   Extending TBCE's role beyond motor neurons: TBCE mutation in pmn mice was shown to cause microtubule disruption in cochlear outer hair cells and auditory nerve, leading to progressive sensorineural hearing loss, broadening the phenotypic spectrum.

   Evidence Immunohistochemistry, ABR/DPOAE electrophysiology, and histopathology in pmn/pmn mouse cochlea

   PMID:24120439

   Open questions at the time

   • Whether hair cell loss is cell-autonomous or secondary to auditory nerve degeneration was not resolved
   • No rescue experiment performed in the cochlear context
5. 2015 High

   Solving the structural basis of heterodimer dissociation: EM reconstruction of the αEB complex and X-ray crystallography of the TBCE UBL domain revealed that TBCE dissociates heterodimers via steric clash between its CAP-Gly/LRR domains and β-tubulin, in an energy-independent mechanism, and that protruding UBL domains may bridge α-tubulin to the proteasome for degradation.

   Evidence Electron microscopy and image processing of the αEB complex; X-ray crystallography of the UBL domain; biochemical dissociation assays

   PMID:25908846

   Open questions at the time

   • Direct evidence for proteasome interaction via the UBL domain was not provided
   • No high-resolution atomic structure of the full αEB complex
6. 2016 High

   Defining hypomorphic TBCE mutations as a cause of progressive encephalopathy with distal SMA: a novel biallelic TBCE mutation was shown to reduce TBCE protein, impair microtubule polymerization kinetics, and disorganize mitotic spindles, expanding the disease spectrum and confirming that partial TBCE loss drives neurodegeneration.

   Evidence Western blot, nocodazole washout re-polymerization assay, immunofluorescence of mitotic spindles in patient fibroblasts

   PMID:27666369

   Open questions at the time

   • The threshold of TBCE activity required to prevent neurodegeneration versus other tissue effects is unknown
   • Whether spindle defects contribute to disease pathogenesis in post-mitotic neurons was not addressed
7. 2021 Medium

   Revealing pharmacological modulation of the TBCE/TBCB dissociation pathway: colchicine was shown to inhibit TBCE/TBCB-mediated heterodimer dissociation, likely by blocking TBCE's interaction with tubulin dimers, providing insight into how microtubule-targeting drugs intersect with the tubulin chaperone cycle.

   Evidence In vitro dissociation assays, cell treatment with colchicine/nocodazole/cold shock, RNAi and overexpression of TBCA, western blot

   PMID:33968934

   Open questions at the time

   • Structural basis of colchicine inhibition of TBCE–tubulin interaction not determined
   • In vivo physiological relevance of colchicine's effect on TBCE pathway not established
8. 2022 Medium

   Implicating TBCE in cancer drug resistance: elevated TBCE expression was linked to platinum resistance in hepatocellular carcinoma, and TBCE silencing reversed resistance by promoting cytoskeletal rearrangement and cisplatin-induced apoptosis in orthotopic and PDX models.

   Evidence RNAseq, siRNA silencing, cell cycle and apoptosis assays, orthotopic and PDX mouse models with nanoparticle co-delivery

   PMID:36970197

   Open questions at the time

   • Mechanism by which TBCE overexpression confers platinum resistance is unclear
   • Whether this is a direct tubulin-chaperone-dependent effect or involves additional TBCE functions is unknown
   • Findings limited to hepatocellular carcinoma; generalizability not tested

• Key unresolved questions include: how TBCE at the Golgi selectively routes tubulin to axons; whether the UBL domain directly engages the proteasome to degrade excess α-tubulin; and the structural basis for tissue-specific vulnerability (motor neurons, parathyroid, pituitary) in TBCE-deficiency disorders.
• No high-resolution structure of the full-length TBCE or complete αEB–proteasome interface
• Mechanism of tissue-specific pathology in TBCE deficiency not established
• Golgi-to-axon tubulin routing mechanism not molecularly defined